Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204010602> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3204010602 endingPage "adv00605" @default.
- W3204010602 startingPage "adv00605" @default.
- W3204010602 abstract "Risankizumab is a humanized monoclonal antibody that binds the p19 subunit of interleukin-23. It is approved for treatment of moderate-severe chronic plaque psoriasis. This retrospective study included 66 consecutive adults with moderate-to-severe psoriasis vulgaris treated with risankizumab in monotherapy up to week 40 in a “real-life” setting. At week 40, 98.7%, 85.7% and 62.3% of patients achieved a Psoriasis Area and Severity Index (PASI) reduction ≥ 75% (PASI 75), PASI 90 and PASI 100, respectively. Patients who had not responded to 2 or more previous biologic treatments were significantly less likely to achieve PASI 75/90 at week 16 and PASI 90/100 at week 40 compared with those who had been previously treated with only 1 biologic, and compared with those treated with risankizumab as a first-line biologic. Increasing body mass index decreased the chances of reaching PASI 90 at week 40. No significant safety findings were recorded throughout the study, and none of the patients had to interrupt the treatment. These data suggest that the efficacy of risankizumab for plaque psoriasis in “real-life” clinical practice could differ from pivotal clinical trials data." @default.
- W3204010602 created "2021-10-11" @default.
- W3204010602 creator A5007545259 @default.
- W3204010602 creator A5014834699 @default.
- W3204010602 creator A5019346097 @default.
- W3204010602 creator A5028135237 @default.
- W3204010602 creator A5035425594 @default.
- W3204010602 creator A5038011040 @default.
- W3204010602 creator A5039411841 @default.
- W3204010602 creator A5047976239 @default.
- W3204010602 creator A5053176930 @default.
- W3204010602 creator A5058842585 @default.
- W3204010602 creator A5063124211 @default.
- W3204010602 creator A5082265951 @default.
- W3204010602 date "2021-11-30" @default.
- W3204010602 modified "2023-09-30" @default.
- W3204010602 title "Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study" @default.
- W3204010602 cites W2067327580 @default.
- W3204010602 cites W2587193484 @default.
- W3204010602 cites W2887412253 @default.
- W3204010602 cites W2944224722 @default.
- W3204010602 cites W2951915926 @default.
- W3204010602 cites W2955205003 @default.
- W3204010602 cites W2964013344 @default.
- W3204010602 cites W3001336221 @default.
- W3204010602 cites W3014609838 @default.
- W3204010602 cites W3020611303 @default.
- W3204010602 cites W3037060742 @default.
- W3204010602 cites W3048245109 @default.
- W3204010602 cites W3094028421 @default.
- W3204010602 cites W3107651834 @default.
- W3204010602 cites W3108317069 @default.
- W3204010602 cites W3131268984 @default.
- W3204010602 doi "https://doi.org/10.2340/actadv.v101.283" @default.
- W3204010602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34596230" @default.
- W3204010602 hasPublicationYear "2021" @default.
- W3204010602 type Work @default.
- W3204010602 sameAs 3204010602 @default.
- W3204010602 citedByCount "21" @default.
- W3204010602 countsByYear W32040106022022 @default.
- W3204010602 countsByYear W32040106022023 @default.
- W3204010602 crossrefType "journal-article" @default.
- W3204010602 hasAuthorship W3204010602A5007545259 @default.
- W3204010602 hasAuthorship W3204010602A5014834699 @default.
- W3204010602 hasAuthorship W3204010602A5019346097 @default.
- W3204010602 hasAuthorship W3204010602A5028135237 @default.
- W3204010602 hasAuthorship W3204010602A5035425594 @default.
- W3204010602 hasAuthorship W3204010602A5038011040 @default.
- W3204010602 hasAuthorship W3204010602A5039411841 @default.
- W3204010602 hasAuthorship W3204010602A5047976239 @default.
- W3204010602 hasAuthorship W3204010602A5053176930 @default.
- W3204010602 hasAuthorship W3204010602A5058842585 @default.
- W3204010602 hasAuthorship W3204010602A5063124211 @default.
- W3204010602 hasAuthorship W3204010602A5082265951 @default.
- W3204010602 hasBestOaLocation W32040106021 @default.
- W3204010602 hasConcept C126322002 @default.
- W3204010602 hasConcept C16005928 @default.
- W3204010602 hasConcept C167135981 @default.
- W3204010602 hasConcept C2777011040 @default.
- W3204010602 hasConcept C2780221984 @default.
- W3204010602 hasConcept C2780564577 @default.
- W3204010602 hasConcept C30036603 @default.
- W3204010602 hasConcept C3020604521 @default.
- W3204010602 hasConcept C71924100 @default.
- W3204010602 hasConcept C90924648 @default.
- W3204010602 hasConceptScore W3204010602C126322002 @default.
- W3204010602 hasConceptScore W3204010602C16005928 @default.
- W3204010602 hasConceptScore W3204010602C167135981 @default.
- W3204010602 hasConceptScore W3204010602C2777011040 @default.
- W3204010602 hasConceptScore W3204010602C2780221984 @default.
- W3204010602 hasConceptScore W3204010602C2780564577 @default.
- W3204010602 hasConceptScore W3204010602C30036603 @default.
- W3204010602 hasConceptScore W3204010602C3020604521 @default.
- W3204010602 hasConceptScore W3204010602C71924100 @default.
- W3204010602 hasConceptScore W3204010602C90924648 @default.
- W3204010602 hasIssue "11" @default.
- W3204010602 hasLocation W32040106021 @default.
- W3204010602 hasLocation W32040106022 @default.
- W3204010602 hasLocation W32040106023 @default.
- W3204010602 hasOpenAccess W3204010602 @default.
- W3204010602 hasPrimaryLocation W32040106021 @default.
- W3204010602 hasRelatedWork W2027592126 @default.
- W3204010602 hasRelatedWork W2028656318 @default.
- W3204010602 hasRelatedWork W2035287048 @default.
- W3204010602 hasRelatedWork W2040737548 @default.
- W3204010602 hasRelatedWork W2060817629 @default.
- W3204010602 hasRelatedWork W2152281374 @default.
- W3204010602 hasRelatedWork W2171689947 @default.
- W3204010602 hasRelatedWork W3184705009 @default.
- W3204010602 hasRelatedWork W4255680485 @default.
- W3204010602 hasRelatedWork W4295255031 @default.
- W3204010602 hasVolume "101" @default.
- W3204010602 isParatext "false" @default.
- W3204010602 isRetracted "false" @default.
- W3204010602 magId "3204010602" @default.
- W3204010602 workType "article" @default.